Published in Pharmacol Res Commun on February 01, 1982
Evidence for a role of oxygen derived free radicals in the pathogenesis of caerulein induced acute pancreatitis in rats. Gut (1988) 1.22
Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity. Biochem J (2001) 0.89
Polynitroxylated starch/TPL attenuates cachexia and increased epithelial permeability associated with TNBS colitis. Inflammation (2002) 0.82
Preformulation development of recombinant pegylated staphylokinase SY161 using statistical design. AAPS PharmSci (2002) 0.75
Airway inflammation induced by xanthine/xanthine oxidase in guinea pigs. Agents Actions (1993) 0.75
Distribution of prostaglandins in inflammatory exudate. J Pathol (1973) 1.45
Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage. Virology (1990) 1.27
Nicotinamide adenine dinucleotide-specific glutamate dehydrogenase of Neurospora. I. Purification and molecular properties. J Biol Chem (1974) 1.13
Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity. Br J Cancer (1998) 1.10
A branched monomethoxypoly(ethylene glycol) for protein modification. Bioconjug Chem (1995) 1.08
Sulfenyl halides as modifying reagents for polypeptides and proteins. 3. Azobenzene-2-sulfenyl bromide, a selective reagent for cysteinyl residues. Biochemistry (1968) 1.07
The origin and turnover of alveolar macrophages in experimental pneumonia. J Pathol (1973) 1.07
Preparation of characterization of poly(ethylene glycol) vinyl sulfone. Bioconjug Chem (1996) 1.06
Stabilization of substances in circulation. Bioconjug Chem (1998) 0.99
Carrageenan oedema in copper-deficient rats. Agents Actions (1978) 0.99
PEGylation of growth hormone-releasing hormone (GRF) analogues. Adv Drug Deliv Rev (2003) 0.98
Glutamate dehydrogenase from Escherichia coli: induction, purification and properties of the enzyme. Biochim Biophys Acta (1975) 0.96
Inactivation of bovine glutamate dehydrogenase by carbamyl phosphate and cyanate. J Biol Chem (1972) 0.96
Effect of calcitonin on different inflammatory models. Agents Actions (1977) 0.96
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf (2007) 0.94
Copper and ceruloplasmin (Cp) concentrations during the acute inflammatory process in the rat. Agents Actions (1982) 0.93
Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment. Clin Exp Rheumatol (1993) 0.93
Concerning the role of endogenous copper in the acute inflammatory process. Agents Actions (1979) 0.93
Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine). Farmaco (2000) 0.92
Reaction of sulfenyl halides with cytochrome c. A novel method for heme cleavage. FEBS Lett (1973) 0.90
Synthesis and characterization of high-molecular mass polyethylene glycol-conjugated oligonucleotides. Bioconjug Chem (1998) 0.90
Antimicrobial drug utilisation in hospitals in Italy and other European countries. Infection (1994) 0.88
On the determination of small amounts of tryptophan metabolites and their occurrence in normal human urine. Clin Chim Acta (1967) 0.88
Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase. Appl Biochem Biotechnol (1985) 0.88
Sulfenyl halides as modifying reagents for polypeptides and proteins. Quantitative evaluation of tryptophan and cystei residues in proteins. Eur J Biochem (1970) 0.88
Drug-protein interactions: evaluation of the binding of antipsychotic drugs to glutamate dehydrogenase by quantitative affinity chromatography. Mol Pharmacol (1979) 0.88
Polyethylene glycol and a novel developed polyethylene glycol-nitric oxide normalize arteriolar response and oxidative stress in ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2006) 0.87
New synthetic amphiphilic polymers for steric protection of liposomes in vivo. J Pharm Sci (1995) 0.87
Isolation and properties of 6-phosphogluconate dehydrogenase from Escherichia coli. Some comparisons with the thermophilic enzyme from Bacillus stearothermophilus. Biochemistry (1976) 0.87
PEG-Ara-C conjugates for controlled release. Eur J Med Chem (2004) 0.86
Effect of calcitonin on carrageenan foot oedema. Agents Actions (1975) 0.86
Nicotinamide adenine dinucleotide-specific glutamate dehydrogenase of Neurospora. II. Selective chemical reactivity of amino and sulfhydryl groups. J Biol Chem (1974) 0.86
Peripheral nerve repair using a poly(organo)phosphazene tubular prosthesis. Biomaterials (1995) 0.85
Copper and zinc status in adjuvant-arthritic rat: studies on blood, liver, kidneys, spleen and inflamed paws. Agents Actions (1988) 0.85
Drug-protein interaction: plasma protein binding of furocoumarins. Farmaco Sci (1979) 0.85
Antihypertensive activity of enalapril. Effect of ibuprofen and different salt intakes. J Clin Hypertens (1987) 0.84
Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury. Transplantation (1996) 0.83
Adjuvant arthritis in young copper-deficient rats. Agents Actions (1978) 0.83
Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers. Bioconjug Chem (1999) 0.83
Spectroscopic characterization of polyethyleneglycol modified superoxide dismutase: 1H NMR studies on its Cu2Co2 derivative. J Inorg Biochem (1990) 0.82
Immunological properties of uricase conjugated to neutral soluble polymers. Bioconjug Chem (2001) 0.82
Copper metabolism during acute inflammation: studies on liver and serum copper concentrations in normal and inflamed rats. Br J Pharmacol (1983) 0.81
Recent results on functional polymers and macromonomers of interest as biomaterials or for biomaterial modification. Biomaterials (1994) 0.81
Distribution of ceftazidime in ascitic fluid. Antimicrob Agents Chemother (1984) 0.80
Copper and zinc status in rats with acute inflammation: focus on the inflamed area. Agents Actions (1988) 0.80
Synthesis and biopharmaceutical characterisation of new poly(hydroxyethylaspartamide) copolymers as drug carriers. Biochim Biophys Acta (2001) 0.80
Synthesis and biological in vitro evaluation of novel PEG-psoralen conjugates. Biomacromolecules (2006) 0.80
Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters. J Pharm Pharmacol (1983) 0.79
Copper metabolism in the acute inflammatory process and its possible significance for a novel approach to the therapy of inflammation. Int J Tissue React (1985) 0.79
Photoinactivation of enzymes by linear and angular furocoumarins. Photochem Photobiol (1982) 0.79
Enzyme modification by MPEG with an amino acid or peptide as spacer arms. Appl Biochem Biotechnol (1991) 0.79
[Pharmacokinetics of cefuroxime and cefoxitin in experimentally induced pleurisy in the rat]. G Ital Chemioter (1982) 0.79
Nicotinamide adenine dinucleotide-specific glutamate dehydrogenase of Neurospora. III. Isolation and sequences of peptides containing selectively labeled lysine and cysteine residues. J Biol Chem (1974) 0.79
The binding of 8-methoxypsoralen by human serum albumin. Farmaco Sci (1978) 0.79
6-Phosphogluconate dehydrogenase from Bacillus stearothermophilus. Methods Enzymol (1982) 0.79
PEG-modified glucose oxidase immobilized on a PVA cryogel membrane for amperometric biosensor applications. Talanta (1998) 0.78
Psychoactive butyrophenones: binding to human and bovine serum albumin. Pharmacol Res Commun (1979) 0.78
Plain and drug loaded polyphosphazene membranes and microspheres in the treatment of rabbit bone defects. J Mater Sci Mater Med (2000) 0.78
Distribution of catalase, ribonuclease and superoxide dismutase modified by monomethoxy (polyethylene glycol) into rat central lymph and lymphatic nodes. Physiol Res (1995) 0.78
Effect of EDTA on the conformational stability of thermolysin. Experientia Suppl (1976) 0.78
Enzymatically active subunits of Bacillus stearothermophilus enolase bound to Sepharose. Int J Pept Protein Res (1984) 0.78
The effect of psoralens and angelicins on proteins in the presence of UV-A irradiation. Photochem Photobiol (1981) 0.78
Purification, characteristics and sequence of a peptide containing an essential lysine residue. Biochim Biophys Acta (1976) 0.78
Copper and zinc status during acute inflammation: studies on blood, liver and kidneys metal levels in normal and inflamed rats. Agents Actions (1986) 0.78
Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation. J Orthop Res (2001) 0.78
Biopolymeric modification of superoxide dismutase (mPEG-SOD) to prevent muscular ischemia-reperfusion damage. Int J Artif Organs (1995) 0.78
Oral zinc as initial therapy in Wilson's disease: two years of continuous treatment in a 10-year-old child. Acta Paediatr (1992) 0.77
Polyphosphazene microspheres for insulin delivery. Int J Pharm (2000) 0.77
Syntheses, chemical and enzymatic stability of new poly(ethylene glycol)-acyclovir prodrugs. Farmaco (2002) 0.77
The modification of ribonuclease-A by near ultraviolet irradiation in the presence of psoralen. Photochem Photobiol (1984) 0.77
Drug-protein interaction: the binding of cephalosporins to albumins. Farmaco Sci (1977) 0.77
Copper supplementation in the rat: preliminary observations on the clinical, hematological and histopathological profile. Agents Actions (1992) 0.77
Effects of monomethoxypoly(ethylene glycol) modification of ribonuclease on antibody recognition, substrate accessibility and conformational stability. J Mol Recognit (1990) 0.77
Indomethacin induced hepatic alterations in mono-oxygenase system and faecal Clostridium perfringens enterotoxin in the rat. Agents Actions (1990) 0.77
Effects of copper and zinc on proteoglycan metabolism in articular cartilage. Mediators Inflamm (1996) 0.77
Eicosanoid and gastroprotection by copper derivatives and NDGA. Inflamm Res (1995) 0.77
Lysosomes as mediators of parenchymal lesions in adjuvant-induced arthritis in rats. J Pathol (1972) 0.77
Purification of a phosphodiesterase from the thermophilic fungus Talaromyces duponti. Hoppe Seylers Z Physiol Chem (1974) 0.76
Evaluation of monomethoxypolyethyleneglycol derivatized superoxide dismutase in blood and evidence for its binding to blood cells. Farmaco (1990) 0.76
Surface modification of enzymes for therapeutic use: monomethoxypoly (ethylene glycol) derivatization of ribonuclease. Farmaco (1992) 0.76
Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems. J Pharm Pharmacol (1996) 0.76
Nimesulide and renal impairment. Eur J Clin Pharmacol (1999) 0.76
Gastric eicosanoid synthesis in normal subjects and alcoholics after ethanol stimulation. Ital J Gastroenterol (1995) 0.76
Pharmacokinetics and distribution of ribonuclease and its monomethoxypoly(ethylene glycol) derivatives in rats. Pharmacol Res (1993) 0.76
General stability of thermophilic enzymes: studies on 6-phosphogluconate dehydrogenase from Bacillus stearothermophilus and yeast. J Appl Biochem (1984) 0.76
[Progress in inflammation applicable to chronic evolutive polyarthritis]. Brux Med (1974) 0.75
Use and safety profile of antiepileptic drugs in Italy. Eur J Clin Pharmacol (2007) 0.75
Tryptophan pyrrolase, kynureninase and kynurenine transaminase activities of human renal tumours. Br J Cancer (1965) 0.75
Antisense activity of an anti-HIV oligonucleotide conjugated to linear and branched high molecular weight polyethylene glycols. Farmaco (1999) 0.75